Advansix announces third quarter 2021 financial results
Parsippany, n.j.--(business wire)--advansix (nyse: asix) today announced its financial results for the third quarter ending september 30, 2021. overall, the company generated robust sales, earnings and cash flow in the quarter reflecting strong execution amid improving end market demand and tight industry supply conditions. third quarter 2021 summary sales up approximately 58% versus prior year driven by 28% favorable impact of market-based pricing, 22% higher raw material pass-through pricing and 8% higher volume net income of $43.9 million, an increase of $44.6 million versus the prior year ebitda of $75.2 million, an increase of $59.4 million versus the prior year ebitda margin of 16.8%, an increase of 1120 bps versus the prior year cash flow from operations of $76.5 million, an increase of $41.0 million versus the prior year capital expenditures of $13.0 million, a decrease of $3.0 million versus the prior year free cash flow of $63.5 million, an increase of $43.9 million versus the prior year announced the initiation of a $0.125 per share quarterly dividend payable november 23, 2021 “we continued to execute well in the third quarter while supporting our customers to successfully navigate the current set of industry dynamics," said erin kane, president and ceo of advansix. "our performance was supported by strong pricing and volume improvement including continued contributions from differentiated products amid favorable end market conditions and tight industry supply. our earnings results were above the high-end of the outlook we provided at our september 28th investor day driven primarily by better-than-expected pricing, net of raw material costs, as well as the timing of ammonium sulfate sales." summary third quarter 2021 financial results for the company are included below: ($ in thousands, except earnings per share) 3q 2021 3q 2020 sales $446,495 $281,910 net income (loss) 43,942 (692) diluted earnings (loss) per share $1.51 ($0.02) ebitda (1) 75,188 15,806 ebitda margin % (1) 16.8% 5.6% cash flow from operations 76,488 35,533 free cash flow (1)(2) 63,495 19,572 (1) see “non-gaap measures” included in this press release for non-gaap reconciliations (2) net cash provided by operating activities less capital expenditures sales of $446.5 million increased approximately 58% versus the prior year. raw material pass-through pricing was favorable by 22% following a net cost increase in benzene and propylene (inputs to cumene which is a key feedstock to our products). market-based pricing was favorable by 28% compared to the prior year driven by higher pricing across each of our product lines. sales volume in the quarter increased approximately 8% driven primarily by improved end market demand across our ammonium sulfate, nylon and caprolactam product lines. sales by product line and approximate percentage of total sales are included below: ($ in thousands) 3q 2021 3q 2020 sales % of total sales % of total nylon $ 122,110 27% $ 73,555 26% caprolactam 80,265 18% 52,409 18% chemical intermediates 130,920 29% 94,770 34% ammonium sulfate 113,200 26% 61,176 22% $ 446,495 100% $ 281,910 100% ebitda of $75.2 million in the quarter increased $59.4 million versus the prior year primarily due to higher market-based pricing, net of increased raw material costs, and the net approximately $20 million favorable impact of planned plant turnarounds year-over-year. 3q 2021 ebitda included approximately $2 million favorable impact of additional insurance proceeds related to the 2019 shutdown of cumene supplier philadelphia energy solutions (pes). earnings per share of $1.51 increased $1.53 versus the prior year driven primarily by the factors discussed above. cash flow from operations of $76.5 million in the quarter increased $41.0 million versus the prior year primarily due to higher net income and the favorable impact of changes in working capital. capital expenditures of $13.0 million in the quarter decreased $3.0 million versus the prior year reflecting capital process efficiencies and timing of project execution. dividend as announced on september 28, 2021, the company's board of directors declared a quarterly cash dividend of $0.125 per share on the company's common stock, payable on november 23, 2021 to stockholders of record as of the close of business on november 9, 2021. credit agreement on october 27, 2021, the company completed a refinancing of its existing credit facility by entering into a new 5-year, $500 million revolving credit facility providing increased liquidity and flexibility at lower borrowing costs reflecting strong business performance and more favorable credit market conditions. outlook expect steady north america nylon demand amid favorable end market conditions and tight industry supply expect robust agricultural industry fundamentals to continue through 2022 planting season expect strong demand for chemical intermediates to continue; expect continued balancing of north america acetone supply and demand expect capital expenditures to be approximately $63 million in 2021; continue to expect $95 to $105 million in 2022 reflecting scope of planned plant turnarounds and timing of project execution expect pre-tax income impact of planned plant turnarounds to be approximately $30 million in 2021 "the outlook for our business remains favorable. we are building off a strong foundation with leading positions across our key product lines aligned to a diverse and growing set of end uses and applications. our enhanced capital allocation strategy, including the recent initiation of a quarterly dividend, is creating further shareholder value over the long-term. we've demonstrated our ability to successfully perform through all market conditions and expand our earnings base and are even more excited about the opportunities that lie ahead for advansix,” concluded kane. conference call information advansix will discuss its results during its investor conference call today starting at 9:00 a.m. et. to participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:00 a.m. et start, and tell the operator that you are dialing in for advansix’s third quarter 2021 earnings call. the live webcast of the investor call as well as related presentation materials can be accessed at http://investors.advansix.com. investors can hear a replay of the conference call from 12 noon et on october 29 until 12 noon et on november 5 by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international). the access code is 10160663. about advansix advansix plays a critical role in global supply chains, innovating and delivering essential products for our customers in a wide variety of end markets and applications that touch people’s lives, such as building and construction, fertilizers, plastics, solvents, packaging, paints, coatings, adhesives and electronics. our reliable and sustainable supply of quality products emerges from the vertically integrated value chain of our three u.s.-based manufacturing facilities. advansix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, chemical intermediates, and plant nutrients, guided by our core values of safety, integrity, accountability and respect. more information on advansix can be found at http://www.advansix.com. forward looking statements this release contains certain statements that may be deemed “forward-looking statements” within the meaning of section 21e of the securities exchange act of 1934, as amended. all statements, other than statements of historical fact, that address activities, events or developments that our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. forward-looking statements may be identified by words such as "expect," "anticipate," "estimate," “outlook,” "project," "strategy," "intend," "plan," "target," "goal," "may," "will," "should" and "believe" and other variations or similar terminology and expressions. although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, many of which are beyond our control and difficult to predict, which may cause the actual results or performance of the company to be materially different from any future results or performance expressed or implied by such forward-looking statements. such risks and uncertainties include, but are not limited to: general economic and financial conditions in the u.s. and globally, including the impact of the coronavirus (covid-19) pandemic and any resurgences; the scope, shape and pace of recovery of the pandemic; the timing of the distribution and efficacy of vaccines or treatments for covid-19 that are currently available or may be available in the future and related vaccination rates; the severity and transmissibility of newly identified strains of covid-19; governmental, business and individuals’ actions in response to the pandemic, including our business continuity and cash optimization plans that have been, and may in the future be, implemented; the impact of social and economic restrictions and other containment measures taken to combat virus transmission; the effect on our customers’ demand for our products and our suppliers’ ability to manufacture and deliver our raw materials, including implications of reduced refinery utilization in the u.s.; our ability to sell and provide our goods and services, including as a result of travel and other covid-19-related restrictions; the ability of our customers to pay for our products; and any closures of our and our customers’ offices and facilities; risks associated with increased phishing, compromised business emails and other cybersecurity attacks and disruptions to our technology infrastructure; risks associated with employees working remotely or operating with a reduced workforce; risks associated with our indebtedness including compliance with financial and restrictive covenants, and our ability to access capital on reasonable terms, at a reasonable cost or at all due to economic conditions resulting from covid-19 or otherwise; the impact of scheduled turnarounds and significant unplanned downtime and interruptions of production or logistics operations as a result of mechanical issues or other unanticipated events such as fires, severe weather conditions, natural disasters and pandemics; price fluctuations, cost increases and supply of raw materials; our operations and growth projects requiring substantial capital; growth rates and cyclicality of the industries we serve including global changes in supply and demand; failure to develop and commercialize new products or technologies; loss of significant customer relationships; adverse trade and tax policies; extensive environmental, health and safety laws that apply to our operations; hazards associated with chemical manufacturing, storage and transportation; litigation associated with chemical manufacturing and our business operations generally; inability to acquire and integrate businesses, assets, products or technologies; protection of our intellectual property and proprietary information; prolonged work stoppages as a result of labor difficulties or otherwise; cybersecurity, data privacy incidents and disruptions to our technology infrastructure; failure to maintain effective internal controls; our ability to declare and pay quarterly cash dividends and the amounts and timing of any future dividends; our ability to repurchase our common stock and the amount and timing of any future repurchases; disruptions in supply chain, transportation and logistics; potential for uncertainty regarding qualification for tax treatment of our spin-off; fluctuations in our stock price; and changes in laws or regulations applicable to our business. you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by such forward-looking statements. we identify the principal risks and uncertainties that affect our performance in our filings with the securities and exchange commission (sec), including the risk factors in part 1, item 1a of our annual report on form 10-k for the year ended december 31, 2020, as updated in subsequent reports filed with the sec. non-gaap financial measures this press release includes certain non-gaap financial measures intended to supplement, not to act as substitutes for, comparable gaap measures. reconciliations of non-gaap financial measures to gaap financial measures are provided in this press release. investors are urged to consider carefully the comparable gaap measures and the reconciliations to those measures provided. non-gaap measures in this press release may be calculated in a way that is not comparable to similarly-titled measures reported by other companies. advansix inc. condensed consolidated balance sheets (unaudited) (dollars in thousands, except share and per share amounts) september 30, 2021 december 31, 2020 assets current assets: cash and cash equivalents $ 7,239 $ 10,606 accounts and other receivables – net 170,941 123,554 inventories – net 142,911 180,085 taxes receivable 337 12,289 other current assets 11,654 6,969 total current assets 333,082 333,503 property, plant and equipment – net 759,373 765,469 operating lease right-of-use assets 142,931 114,484 goodwill 17,592 15,005 other assets 37,384 34,946 total assets $ 1,290,362 $ 1,263,407 liabilities current liabilities: accounts payable $ 217,993 $ 190,227 accrued liabilities 48,315 41,152 operating lease liabilities – short-term 36,694 29,279 deferred income and customer advances 3,138 26,379 total current liabilities 306,140 287,037 deferred income taxes 137,241 125,575 operating lease liabilities – long-term 106,773 85,605 line of credit – long-term 135,000 275,000 postretirement benefit obligations 27,119 39,168 other liabilities 11,778 6,899 total liabilities 724,051 819,284 stockholders' equity common stock, par value $0.01; 200,000,000 shares authorized; 31,738,648 shares issued and 28,124,446 outstanding at september 30, 2021; 31,627,139 shares issued and 28,033,227 outstanding at december 31, 2020 317 316 preferred stock, par value $0.01; 50,000,000 shares authorized and 0 shares issued and outstanding at september 30, 2021 and december 31, 2020 — — treasury stock at par (3,614,202 shares at september 30, 2021; 3,593,912 shares at december 31, 2020) (36 ) (36 ) additional paid-in capital 192,950 184,732 retained earnings 387,932 275,243 accumulated other comprehensive loss (14,852 ) (16,132 ) total stockholders' equity 566,311 444,123 total liabilities and stockholders' equity $ 1,290,362 $ 1,263,407 advansix inc. condensed consolidated statements of operations (unaudited) (dollars in thousands, except share and per share amounts) three months ended september 30, nine months ended september 30, 2021 2020 2021 2020 sales $ 446,495 $ 281,910 $ 1,260,561 $ 817,644 costs, expenses and other: costs of goods sold 366,180 265,758 1,040,965 736,504 selling, general and administrative expenses 21,121 16,177 62,112 50,827 interest expense, net 1,174 1,981 4,096 5,827 other non-operating expense (income), net 331 (334 ) 349 216 total costs, expenses and other 388,806 283,582 1,107,522 793,374 income (loss) before taxes 57,689 (1,672 ) 153,039 24,270 income tax expense (benefit) 13,747 (980 ) 36,835 4,957 net income (loss) $ 43,942 $ (692 ) $ 116,204 $ 19,313 earnings (loss) per common share basic $ 1.56 $ (0.02 ) $ 4.13 $ 0.69 diluted $ 1.51 $ (0.02 ) $ 4.02 $ 0.69 weighted average common shares outstanding basic 28,182,810 28,079,937 28,136,511 28,037,651 diluted 29,100,276 28,079,937 28,920,832 28,092,712 advansix inc. condensed consolidated statements of cash flows (unaudited) (dollars in thousands) three months ended september 30, nine months ended september 30, 2021 2020 2021 2020 cash flows from operating activities: net income $ 43,942 $ (692 ) $ 116,204 $ 19,313 adjustments to reconcile net income to net cash provided by operating activities: depreciation and amortization 16,325 15,497 49,058 45,061 loss on disposal of assets 409 95 842 143 deferred income taxes 3,423 1,389 11,235 11,895 stock-based compensation 2,499 603 8,606 3,503 accretion of deferred financing fees 142 141 424 412 changes in assets and liabilities, net of business acquisitions: accounts and other receivables (5,575 ) (22,385 ) (46,549 ) 7,445 inventories (2,807 ) 9,851 37,885 (2,163 ) taxes receivable 26 (3,634 ) 11,952 (11,760 ) accounts payable 20,226 31,285 27,047 (9,939 ) accrued liabilities 1,843 1,840 6,418 7,776 deferred income and customer advances 188 913 (23,241 ) (13,520 ) other assets and liabilities (4,153 ) 630 (14,358 ) 5,920 net cash provided by operating activities 76,488 35,533 185,523 64,086 cash flows from investing activities: expenditures for property, plant and equipment (12,993 ) (15,961 ) (37,471 ) (67,563 ) acquisition of business — — (9,523 ) — other investing activities (493 ) (373 ) (975 ) (898 ) net cash used for investing activities (13,486 ) (16,334 ) (47,969 ) (68,461 ) cash flows from financing activities: borrowings from line of credit 29,000 49,000 133,500 268,500 payments of line of credit (89,000 ) (124,000 ) (273,500 ) (252,500 ) payment of line of credit facility fees — — — (425 ) principal payments of finance leases (170 ) (176 ) (534 ) (534 ) purchase of treasury stock — — (589 ) (1,032 ) issuance of common stock 156 — 202 2 net cash provided by (used for) financing activities (60,014 ) (75,176 ) (140,921 ) 14,011 net change in cash and cash equivalents 2,988 (55,977 ) (3,367 ) 9,636 cash and cash equivalents at beginning of period 4,251 72,663 10,606 7,050 cash and cash equivalents at the end of period $ 7,239 $ 16,686 $ 7,239 $ 16,686 supplemental non-cash investing activities: capital expenditures included in accounts payable $ 6,783 $ 5,802 advansix inc. non-gaap measures (dollars in thousands) reconciliation of net cash provided by operating activities to free cash flow three months ended september 30, nine months ended september 30, 2021 2020 2021 2020 net cash provided by operating activities $ 76,488 $ 35,533 $ 185,523 $ 64,086 expenditures for property, plant and equipment (12,993 ) (15,961 ) (37,471 ) (67,563 ) free cash flow (1) $ 63,495 $ 19,572 $ 148,052 $ (3,477 ) (1) free cash flow is a non-gaap measure defined as net cash provided by operating activities less expenditures for property, plant and equipment the company believes that this metric is useful to investors and management as a measure to evaluate our ability to generate cash flow from business operations and the impact that this cash flow has on our liquidity. reconciliation of net income to ebitda three months ended september 30, nine months ended september 30, 2021 2020 2021 2020 net income (loss) $ 43,942 $ (692 ) $ 116,204 $ 19,313 interest expense, net 1,174 1,981 4,096 5,827 income tax expense (benefit) 13,747 (980 ) 36,835 4,957 depreciation and amortization 16,325 15,497 49,058 45,061 ebitda (2) $ 75,188 $ 15,806 $ 206,193 $ 75,158 sales $ 446,495 $ 281,910 $ 1,260,561 $ 817,644 ebitda margin (3) 16.8 % 5.6 % 16.4 % 9.2 % (2) ebitda is a non-gaap measure defined as net income before interest, income taxes, depreciation and amortization (3) ebitda margin is defined as ebitda divided by sales the company believes the non-gaap financial measures presented in this release provide meaningful supplemental information as they are used by the company’s management to evaluate the company’s operating performance, enhance a reader’s understanding of the financial performance of the company, and facilitate a better comparison among fiscal periods and performance relative to its competitors, as these non-gaap measures exclude items that are not considered core to the company’s operations. advansix inc. appendix (pre-tax income impact, dollars in millions) planned plant turnaround schedule (4) 1q 2q 3q 4q fy 2017 — ~$10 ~$4 ~$20 ~$34 2018 ~$2 ~$10 ~$30 — ~$42 2019 — ~$5 ~$5 ~$25 ~$35 2020 ~$2 ~$7 ~$20 ~$2 ~$31 2021e ~$3 ~$8 — ~$19 ~$30 (4) primarily reflects the impact of fixed cost absorption, maintenance expense, and the purchase of feedstocks which are normally manufactured by the company.
